MD Pediatrix Medical Group, Inc.

$26.86 -0.02%

Updated 16 d ago

Pediatrix Medical Group, Inc. (MD) is a healthcare company in the Services-Hospitals industry, with a market capitalization of $2.2 billion. Shares last traded at $26.86, 5.6% below their 52-week high. Over the past year the stock is up 61.8%. MD trades at a price-to-earnings ratio of 12.49, below the Healthcare median of 27.46. Net profit margin is 9.0%, above the peer median of -1.5%. Revenue declined 4.9% year over year.

Market Cap

$2.2B

Shares Out

81.3M

EPS (TTM)

$3.45

P/E Ratio

7.79

P/S Ratio

1.12

P/B Ratio

2.48

Dividend / Share

—

Dividend Yield

—

52-Week High

$28.45

52-Week Low

$15.70

Volume

25,207

Avg Vol (3m)

38,542.317

Performance

+0.26%

+3.37%

+20.09%

+39.27%

YTD

+26.13%

+61.84%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

55.76

SMA (50)

$26.23

SMA (200)

$22.96

Price vs SMA50

+2.42%

Price vs SMA200

+17.00%

ATR (14)

$0.84

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$2.0B

Net Income

$175M

Gross Margin

—

Operating Margin

11.0%

Net Margin

9.0%

Return on Equity

19.8%

Return on Assets

8.2%

Current Ratio

1.32

Debt / Equity

0.69

Revenue Growth (YoY)

-4.9%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$0.85	2026-08-04
Q1 2026	$0.36	2026-05-05
FY 2025	$1.94	2026-02-19
Q3 2025	$1.54	2025-11-03
Q2 2026	$0.70	2026-08-04
Q1 2026	$0.24	2026-05-05

Full earnings history →

Healthcare peers

MD vs 14 sector peers (Healthcare), by market cap. Updated 16 d ago

P/E vs peers

12.49 / 27.46 med

-55% discount

P/S vs peers

1.12 / 4.47 med

-75% discount

Net margin vs peers

9.0% / -1.5% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
AMGN	Amgen	$240.1B	27.47	6.30	23.0%	+0.31%
TMO	Thermo Fisher Scientific	$228.7B	32.82	4.94	15.0%	+1.66%
KLAC	KLA Corporation	$225.9B	46.76	16.64	35.6%	+0.37%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
GILD	Gilead Sciences	$187.5B	-57.87	6.16	-10.6%	+1.09%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
DHR	Danaher Corporation	$148.3B	37.05	5.91	15.9%	+0.49%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.